Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ro is a direct-to-patient healthcare company that integrates telehealth, diagnostics, and pharmacy services into a single vertical platform. Founded in 2017, the company initially launched as Roman, focusing on men's health, but has since expanded into women's health (Rory), smoking cessation (Zero), and weight management (Ro Body). Ro provides end-to-end care by connecting patients with licensed providers for consultations, facilitating lab testing, and delivering medications directly to patients' homes. The company has gained significant traction in the weight loss space by offering access to GLP-1 medications alongside coaching and metabolic testing.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ro-papav.